René dePont Christensen

statistician, PhD

20022019
If you made any changes in Pure these will be visible here soon.

Personal profile

Research areas

Design and analysis of randomized trials. Epidemiological studies of chronic diseases and pharmacoepidemiological studies of drugs' long term effects and side effects.
Participation in a number of research projects and
Co-supervisor / consultant with regard to statistics on a number of Ph.D. projects.

Fingerprint Dive into the research topics where René dePont Christensen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 45 Similar Profiles
Population Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Randomized Controlled Trials Medicine & Life Sciences
Cohort Studies Medicine & Life Sciences
General Practice Medicine & Life Sciences
General Practitioners Medicine & Life Sciences
Colonic Neoplasms Medicine & Life Sciences
Denmark Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24

Mirza, M. R., Bergmann, T. K., Mau-Sørensen, M., Christensen, R. D., Åvall-Lundqvist, E., Birrer, M. J., Jørgensen, M., Roed, H., Malander, S., Nielsen, F., Lassen, U., Brøsen, K., Bjørge, L. & Mäenpää, J., Oct 2019, In : Cancer Chemotherapy and Pharmacology. 84, 4, p. 791-798

Research output: Contribution to journalJournal articleResearchpeer-review

Platinum
Angiogenesis Inhibitors
Germ-Line Mutation
Ovarian Neoplasms
Disease-Free Survival
Traffic Accidents
Denmark
Case-Control Studies
Comorbidity
Hypnotics and Sedatives

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial

AVANOVA investigators, Oct 2019, In : The Lancet Oncology. 20, 10, p. 1409-1419

Research output: Contribution to journalJournal articleResearchpeer-review

Platinum
Ovarian Neoplasms
Disease-Free Survival
Bevacizumab
niraparib

Postponement of Death by Statin Use: a Systematic Review and Meta-analysis of Randomized Clinical Trials

Hansen, M. R., Hróbjartsson, A., Pottegård, A., Damkier, P., Larsen, K. S., Madsen, K. G., dePont Christensen, R., Kristensen, M. E. L., Christensen, P. M. & Hallas, J., 15. Aug 2019, In : Journal of General Internal Medicine. 34, 8, p. 1607-1614

Research output: Contribution to journalReviewResearchpeer-review

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Meta-Analysis
Randomized Controlled Trials
Numbers Needed To Treat
Risk Reduction Behavior
Colorectal Neoplasms
Cohort Studies
Population
Delivery of Health Care
Early Detection of Cancer

Activities 2017 2017

  • 1 Conference presentations

Building Nurse Navigation in colorectal cancer care

Marianne Kirstine Thygesen (Lecturer), Llise Fillion (Other), Jens Søndergaard (Other), René dePont Christensen (Other), Karin Brochstedt Dieperink (Other), Niels Qvist (Other)
9. May 2017

Activity: Talks and presentationsConference presentations